GLP-1 For Weight Loss Is Now Available In Asbury Park NJ
Semaglutide, a GLP-1 medication that was originally used to treat type 2 diabetes, has recently gained approval for use as a weight loss aid. The medication, sold under the brand name Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it works by stimulating the production of insulin and suppressing the appetite. The medication is now avaialable as a custom blended medication by doctors at the Jersey Weight Loss Clinic who are accepting patients from Asbury Park, NJ for their Doctor prescribed weight loss program.
The approval of semaglutide for weight loss has been a game changer for many individuals struggling with obesity. According to the World Health Organization, over 1.9 billion adults worldwide are overweight, with 650 million of those being classified as obese. Obesity is a serious health concern that is associated with an increased risk of many chronic diseases, including type 2 diabetes, heart disease, and certain cancers. Semaglutide offers a new, effective option for those looking to lose weight and improve their overall health.
In clinical trials, semaglutide has been shown to be highly effective in promoting weight loss. The STEP (Semaglutide Treatment Effect in People with Obesity) program, which included over 4,500 participants, found that individuals who took semaglutide lost an average of 15% of their body weight, compared to just 2.4% for those who received a placebo. This weight loss was sustained over a 68-week period, with participants continuing to lose weight even after the medication was discontinued.
Semaglutide and other GLP-1 are taken once a week by subcutaneous injection.
One of the benefits of the GLP-1 is that it not only promotes weight loss but also offers other health benefits. In addition to helping individuals lose weight, semaglutide has been shown to improve glycemic control in individuals with type 2 diabetes, lower blood pressure, and improve lipid profiles. These benefits can lead to a significant reduction in the risk of many chronic diseases.
As with any medication, there are potential side effects associated with semaglutide. The most common side effects reported in clinical trials were nausea, diarrhea, vomiting, and constipation. However, these side effects were generally mild to moderate and tended to decrease over time.
Semaglutide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). However, it is important to note that anyone seeking to use this medication should discuss it with their physician or you can get a free consultation at the Jersey Weight Loss CLinic to see if you are a candidate.
Overall, semaglutide offers a promising new option for individuals struggling with obesity. It has been shown to be highly effective in promoting weight loss, and also offers other health benefits. However, it is important to use semaglutide as directed and to discuss any potential side effects with a healthcare provider. If you live in Asbury Park or the surrounding area callAt Jersey Weight Loss Clinic, our team of healthcare professionals that practice medical weight loss in NJ can help determine if semaglutide is right for you and provide support throughout your weight loss journey.